148 related articles for article (PubMed ID: 33488123)
21. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis.
Liu X; Shen Z
Am J Med Sci; 2020 Dec; 360(6):711-720. PubMed ID: 32988599
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA TMPO-AS1 promotes tumor progression via sponging miR-140-5p in breast cancer.
Zhu D; Lv W; Zhou X; He Y; Yao H; Yu Y; Zhang G; Zhang Q
Exp Ther Med; 2021 Jan; 21(1):17. PubMed ID: 33235626
[TBL] [Abstract][Full Text] [Related]
23. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
Yang J; Liang B; Hou S
J Gene Med; 2019 Nov; 21(11):e3125. PubMed ID: 31483914
[TBL] [Abstract][Full Text] [Related]
24. The Long Non-coding RNA TMPO-AS1 Promotes Bladder Cancer Growth and Progression
Zhang Y; Zhu Y; Xiao M; Cheng Y; He D; Liu J; Xiang L; Gong L; Wang Z; Deng L; Cao K
Front Oncol; 2021; 11():643163. PubMed ID: 33816295
[No Abstract] [Full Text] [Related]
25. TMPO-AS1, a Novel E2F1-Regulated lncRNA, Contributes to the Proliferation of Lung Adenocarcinoma Cells via Modulating miR-326/SOX12 Axis.
Wei L; Liu Y; Zhang H; Ma Y; Lu Z; Gu Z; Ding C
Cancer Manag Res; 2020; 12():12403-12414. PubMed ID: 33293866
[TBL] [Abstract][Full Text] [Related]
26. CDKN2B-AS1 promotes the proliferation, clone formation, and invasion of nasopharyngeal carcinoma cells by regulating miR-98-5p/E2F2 axis.
Li Z; Cai X; Zou W; Zhang J
Am J Transl Res; 2021; 13(12):13406-13422. PubMed ID: 35035684
[TBL] [Abstract][Full Text] [Related]
27. LncRNA IGBP1-AS1 targets miR-150-5p to increase ZEB1 expression in nasopharyngeal carcinoma.
Wang LJ; Wang YS; Zhao Y
Transl Cancer Res; 2022 Mar; 11(3):530-537. PubMed ID: 35402187
[TBL] [Abstract][Full Text] [Related]
28. TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.
Luo H; Yang L; Liu C; Wang X; Dong Q; Liu L; Wei Q
Int J Biochem Cell Biol; 2020 May; 122():105702. PubMed ID: 32087328
[TBL] [Abstract][Full Text] [Related]
29. Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis.
Yang X; Lin F; Gao F
Int J Biol Markers; 2020 Dec; 35(4):61-70. PubMed ID: 32962500
[TBL] [Abstract][Full Text] [Related]
30. LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer.
Zhao H; Ding F; Zheng G
FASEB J; 2020 Sep; 34(9):11382-11394. PubMed ID: 32692467
[TBL] [Abstract][Full Text] [Related]
31. LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2).
Yao H; Yang L; Tian L; Guo Y; Li Y
Cancer Cell Int; 2020; 20():138. PubMed ID: 32368184
[TBL] [Abstract][Full Text] [Related]
32. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis.
Zhu H; Zhai B; He C; Li Z; Gao H; Niu Z; Jiang X; Lu J; Sun X
Cell Death Dis; 2020 Aug; 11(8):637. PubMed ID: 32801339
[TBL] [Abstract][Full Text] [Related]
33. LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1.
Liu X; Wang H; Tao GL; Chu TB; Wang YX; Liu L
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11006-11015. PubMed ID: 33215415
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway.
Lian Y; Xiong F; Yang L; Bo H; Gong Z; Wang Y; Wei F; Tang Y; Li X; Liao Q; Wang H; Zhou M; Xiang B; Wu X; Li Y; Li X; Chen X; Li G; Guo C; Zeng Z; Xiong W
J Exp Clin Cancer Res; 2018 Oct; 37(1):253. PubMed ID: 30326930
[TBL] [Abstract][Full Text] [Related]
37. LncRNA HOXC-AS1 promotes nasopharyngeal carcinoma (NPC) progression by sponging miR-4651 and subsequently upregulating FOXO6.
Tang Z; Zeng X; Li J; Qiu S; Zhao H; Wang Z; Zheng Y
J Pharmacol Sci; 2021 Nov; 147(3):284-293. PubMed ID: 34507637
[TBL] [Abstract][Full Text] [Related]
38. KIF9-AS1 promotes nasopharyngeal carcinoma progression by suppressing miR-16.
You H; Wang S; Yu S
Oncol Lett; 2020 Nov; 20(5):241. PubMed ID: 32973955
[TBL] [Abstract][Full Text] [Related]
39. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
Cui H; Zhao J
J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA ROR1-AS1 induces tumor metastasis and epithelial-mesenchymal transition by sponging miR-375 in nasopharyngeal carcinoma.
Hou J; Yan J; Ren XY; Zhu K; Du XY; Li JJ; Xu M
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):174-180. PubMed ID: 31957830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
